Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Global data on visual impairment in the year 2002.
4.209
Zitationen
7
Autoren
2004
Jahr
Abstract
This paper presents estimates of the prevalence of visual impairment and its causes in 2002, based on the best available evidence derived from recent studies. Estimates were determined from data on low vision and blindness as defined in the International statistical classification of diseases, injuries and causes of death, 10th revision. The number of people with visual impairment worldwide in 2002 was in excess of 161 million, of whom about 37 million were blind. The burden of visual impairment is not distributed uniformly throughout the world: the least developed regions carry the largest share. Visual impairment is also unequally distributed across age groups, being largely confined to adults 50 years of age and older. A distribution imbalance is also found with regard to gender throughout the world: females have a significantly higher risk of having visual impairment than males. Notwithstanding the progress in surgical intervention that has been made in many countries over the last few decades, cataract remains the leading cause of visual impairment in all regions of the world, except in the most developed countries. Other major causes of visual impairment are, in order of importance, glaucoma, age-related macular degeneration, diabetic retinopathy and trachoma.
Ähnliche Arbeiten
The number of people with glaucoma worldwide in 2010 and 2020
2006 · 7.384 Zit.
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 · 6.876 Zit.
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 · 5.851 Zit.
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
2016 · 5.332 Zit.
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
2014 · 5.208 Zit.